Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells - PubMed (original) (raw)
. 2003 Jan 31;278(5):3275-85.
doi: 10.1074/jbc.M204623200. Epub 2002 Nov 5.
Affiliations
- PMID: 12421823
- DOI: 10.1074/jbc.M204623200
Free article
Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells
Nancy Dumont et al. J Biol Chem. 2003.
Free article
Abstract
Transforming growth factor-beta (TGF-beta) is a pleiotropic growth factor that plays a critical role in modulating cell growth, differentiation, and plasticity. There is increasing evidence that after cells lose their sensitivity to TGF-beta-mediated growth inhibition, autocrine TGF-beta signaling may potentially promote tumor cell motility and invasiveness. To understand the molecular mechanisms by which autocrine TGF-beta may selectively contribute to tumor cell motility, we have generated MDA-MB-231 breast cancer cells stably expressing a kinase-inactive type II TGF-beta receptor (T beta RII-K277R). Our data indicate that T beta RII-K277R is expressed, can associate with the type I TGF-beta receptor, and block both Smad-dependent and -independent signaling pathways activated by TGF-beta. In addition, wound closure and transwell migration assays indicated that the basal migratory potential of T beta RII-K277R expressing cells was impaired. The impaired motility of T beta RII-K277R cells could be restored by reconstituting TGF-beta signaling with a constitutively active TGF-beta type I receptor (ALK5(TD)) but not by reconstituting Smad signaling with Smad2/4 or Smad3/4 expression. In addition, the levels of ALK5(TD) expression sufficient to restore motility in the cells expressing T beta RII-K277R were associated with an increase in phosphorylation of Akt and extracellular signal-regulated kinase 1/2 but not Smad2. These data indicate that different signaling pathways require different thresholds of TGF-beta activation and suggest that TGF-beta promotes motility through mechanisms independent of Smad signaling, possibly involving activation of the phosphatidylinositol 3-kinase/Akt and/or mitogen-activated protein kinase pathways.
Similar articles
- Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL. Ueda Y, et al. J Biol Chem. 2004 Jun 4;279(23):24505-13. doi: 10.1074/jbc.M400081200. Epub 2004 Mar 24. J Biol Chem. 2004. PMID: 15044465 - Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
Wang J, Sergina N, Ko TC, Gong J, Brattain MG. Wang J, et al. J Biol Chem. 2004 Sep 17;279(38):40237-44. doi: 10.1074/jbc.M401665200. Epub 2004 Jul 22. J Biol Chem. 2004. PMID: 15271980 - Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
Zeeh F, Witte D, Gädeken T, Rauch BH, Grage-Griebenow E, Leinung N, Fromm SJ, Stölting S, Mihara K, Kaufmann R, Settmacher U, Lehnert H, Hollenberg MD, Ungefroren H. Zeeh F, et al. Oncotarget. 2016 Jul 5;7(27):41095-41109. doi: 10.18632/oncotarget.9600. Oncotarget. 2016. PMID: 27248167 Free PMC article. - Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D, Burch ML, Piva TJ, Rezaei HB, Rostam MA, Xu S, Zheng W, Little PJ, Osman N. Kamato D, et al. Cell Signal. 2013 Oct;25(10):2017-24. doi: 10.1016/j.cellsig.2013.06.001. Epub 2013 Jun 11. Cell Signal. 2013. PMID: 23770288 Review. - Autocrine TGF-β in Cancer: Review of the Literature and Caveats in Experimental Analysis.
Ungefroren H. Ungefroren H. Int J Mol Sci. 2021 Jan 19;22(2):977. doi: 10.3390/ijms22020977. Int J Mol Sci. 2021. PMID: 33478130 Free PMC article. Review.
Cited by
- TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression.
Daroqui MC, Vazquez P, Bal de Kier Joffé E, Bakin AV, Puricelli LI. Daroqui MC, et al. Oncol Rep. 2012 Aug;28(2):567-75. doi: 10.3892/or.2012.1813. Epub 2012 May 14. Oncol Rep. 2012. PMID: 22614218 Free PMC article. - TGFbeta signaling supports survival and metastasis of endometrial cancer cells.
Lei X, Wang L, Yang J, Sun LZ. Lei X, et al. Cancer Manag Res. 2009 Apr;2009(1):15-24. Cancer Manag Res. 2009. PMID: 20622970 Free PMC article. - Suppression of latent transforming growth factor (TGF)-beta1 restores growth inhibitory TGF-beta signaling through microRNAs.
Dogar AM, Towbin H, Hall J. Dogar AM, et al. J Biol Chem. 2011 May 6;286(18):16447-58. doi: 10.1074/jbc.M110.208652. Epub 2011 Mar 14. J Biol Chem. 2011. PMID: 21402698 Free PMC article. - Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase.
Fini MA, Orchard-Webb D, Kosmider B, Amon JD, Kelland R, Shibao G, Wright RM. Fini MA, et al. J Cell Biochem. 2008 Nov 1;105(4):1008-26. doi: 10.1002/jcb.21901. J Cell Biochem. 2008. PMID: 18767115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous